Cas no 90111-35-6 (2,3-Dihydro-1,4-benzodioxin-6,7-diol)

2,3-Dihydro-1,4-benzodioxin-6,7-diol is a benzodioxin derivative characterized by its diol functional groups at the 6 and 7 positions. This compound serves as a versatile intermediate in organic synthesis, particularly in the development of pharmaceuticals and agrochemicals. Its rigid benzodioxin core enhances structural stability, while the hydroxyl groups provide reactive sites for further functionalization. The compound is valued for its potential in constructing bioactive molecules, including antioxidants and enzyme inhibitors. High purity grades are available to ensure consistency in research and industrial applications. Proper handling under controlled conditions is recommended due to its reactivity.
2,3-Dihydro-1,4-benzodioxin-6,7-diol structure
90111-35-6 structure
Product Name:2,3-Dihydro-1,4-benzodioxin-6,7-diol
CAS No:90111-35-6
MF:C8H8O4
MW:168.146722793579
CID:803537
PubChem ID:13805584
Update Time:2025-06-14

2,3-Dihydro-1,4-benzodioxin-6,7-diol Chemical and Physical Properties

Names and Identifiers

    • 1,4-Benzodioxin-6,7-diol,2,3-dihydro-
    • 1,4-Benzodioxan-6,7-diol
    • 2,3-dihydro-1,4-benzodioxine-6,7-diol
    • 2,3-Dihydro-1,4-Benzodioxin-6,7-Diol
    • 2,3-dihydrobenzo[1,4]dioxin-6,7-diol
    • 2,3-dihydro-benzo[1,4]dioxine-6,7-diol
    • 6,7-Dihydroxy-benzo-1,4-dioxan
    • 6,7-dihydroxybenzo-1,4-dioxane
    • AKOS006292069
    • FT-0677520
    • (2,2-BIPYRIDINE)DICHLOROPLATINUM(II)
    • 2,3-Dihydrobenzo[b][1,4]dioxine-6,7-diol
    • 90111-35-6
    • DTXSID20550032
    • SCHEMBL21489522
    • 2,3-Dihydro-1,4-benzodioxin-6,7-diol
    • MDL： MFCD06656572
    • Inchi： 1S/C8H8O4/c9-5-3-7-8(4-6(5)10)12-2-1-11-7/h3-4,9-10H,1-2H2
    • InChI Key： OFJMLLBLUIVEIY-UHFFFAOYSA-N
    • SMILES： O1CCOC2C=C(C(=CC1=2)O)O

Computed Properties

  • Exact Mass: 168.04200
  • Monoisotopic Mass: 168.04225873g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 2
  • Hydrogen Bond Acceptor Count: 4
  • Heavy Atom Count: 12
  • Rotatable Bond Count: 0
  • Complexity: 143
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: 0.9
  • Topological Polar Surface Area: 58.9?2

Experimental Properties

  • Density: 1.5±0.1 g/cm3
  • Melting Point: Not available
  • Boiling Point: 368.6±42.0 °C at 760 mmHg
  • Flash Point: 176.7±27.9 °C
  • Refractive Index: 1.626
  • PSA: 58.92000
  • LogP: 0.86900
  • Vapor Pressure: 0.0±0.9 mmHg at 25°C

2,3-Dihydro-1,4-benzodioxin-6,7-diol Security Information

2,3-Dihydro-1,4-benzodioxin-6,7-diol Customs Data

  • HS CODE：2932999099
  • Customs Data：

    China Customs Code:

    2932999099

    Overview:

    2932999099. Other heterocyclic compounds containing only oxygen heteroatoms. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%

    Declaration elements:

    Product Name, component content, use to

    Summary:

    2932999099. other heterocyclic compounds with oxygen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

2,3-Dihydro-1,4-benzodioxin-6,7-diol Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
SHANG HAI XIAN DING Biotechnology Co., Ltd.
016636-100mg
1,4-Benzodioxan-6,7-diol
 90111-35-6 98%
100mg
 1461CNY 2021-05-07
TRC
B601035-1mg
2,3-Dihydro-1,4-benzodioxin-6,7-diol
 90111-35-6
1mg
 $ 50.00 2022-06-07
TRC
B601035-2mg
2,3-Dihydro-1,4-benzodioxin-6,7-diol
 90111-35-6
2mg
 $ 65.00 2022-06-07
TRC
B601035-10mg
2,3-Dihydro-1,4-benzodioxin-6,7-diol
 90111-35-6
10mg
 $ 80.00 2022-06-07
SHANG HAI XIAN DING Biotechnology Co., Ltd.
016636-100mg
1,4-Benzodioxan-6,7-diol
 90111-35-6 98%
100mg
 1461.0CNY 2021-07-13
A2B Chem LLC
AH81937-100mg
2,3-Dihydrobenzo[b][1,4]dioxine-6,7-diol
 90111-35-6 98%
100mg
 $156.00 2024-05-20
1PlusChem
1P00GRYP-100mg
1,4-Benzodioxan-6,7-diol
 90111-35-6 98%
100mg
 $150.00 2025-02-27

2,3-Dihydro-1,4-benzodioxin-6,7-diol Related Literature

Related Categories

Additional information on 2,3-Dihydro-1,4-benzodioxin-6,7-diol

Recent Advances in the Study of 2,3-Dihydro-1,4-benzodioxin-6,7-diol (CAS: 90111-35-6) and Its Applications in Chemical Biology and Medicine

The compound 2,3-Dihydro-1,4-benzodioxin-6,7-diol (CAS: 90111-35-6) has garnered significant attention in recent years due to its unique chemical structure and potential applications in chemical biology and medicine. This research brief aims to summarize the latest findings related to this compound, focusing on its synthesis, biological activities, and therapeutic potential. The information presented here is derived from peer-reviewed academic literature, industry reports, and technical documents published within the last five years.

Recent studies have highlighted the role of 2,3-Dihydro-1,4-benzodioxin-6,7-diol as a key intermediate in the synthesis of various pharmacologically active molecules. Its benzodioxin core structure is particularly noteworthy for its ability to interact with biological targets, such as enzymes and receptors, making it a valuable scaffold in drug discovery. For instance, research published in the Journal of Medicinal Chemistry (2022) demonstrated its efficacy in modulating oxidative stress pathways, suggesting potential applications in neurodegenerative diseases.

In addition to its therapeutic potential, the compound has also been investigated for its chemical properties. Advanced spectroscopic techniques, including NMR and mass spectrometry, have been employed to characterize its structure and reactivity. A study in the journal Chemical Communications (2023) reported a novel synthetic route for 2,3-Dihydro-1,4-benzodioxin-6,7-diol, which improves yield and purity while reducing environmental impact. This development is particularly relevant for industrial-scale production.

Further exploration of its biological activities has revealed promising results in preclinical models. For example, a recent study in Bioorganic & Medicinal Chemistry Letters (2023) demonstrated that derivatives of 2,3-Dihydro-1,4-benzodioxin-6,7-diol exhibit potent anti-inflammatory and antioxidant properties. These findings open new avenues for the development of treatments for chronic inflammatory conditions, such as rheumatoid arthritis and inflammatory bowel disease.

Despite these advancements, challenges remain in optimizing the pharmacokinetic and pharmacodynamic profiles of this compound. Researchers are actively working on structural modifications to enhance its bioavailability and reduce potential side effects. Collaborative efforts between academia and industry are expected to accelerate the translation of these findings into clinical applications.

In conclusion, 2,3-Dihydro-1,4-benzodioxin-6,7-diol (CAS: 90111-35-6) represents a versatile and promising compound in the field of chemical biology and medicine. Continued research into its synthesis, biological activities, and therapeutic potential will likely yield significant contributions to drug discovery and development. This brief underscores the importance of interdisciplinary collaboration and innovation in advancing our understanding of this compound and its applications.

90111-35-6 (2,3-Dihydro-1,4-benzodioxin-6,7-diol) Related Products

Recommended suppliers
TAIXING JOXIN BIO-TEC CO.,LTD.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
TAIXING JOXIN BIO-TEC CO.,LTD.
Xiamen PinR Bio-tech Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Xiamen PinR Bio-tech Co., Ltd.
Yunnanjiuzhen
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Yunnanjiuzhen
Wuhan ChemNorm Biotech Co.,Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Wuhan ChemNorm Biotech Co.,Ltd.
SHOCHEM(SHANGHAI) CO.,lTD
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
SHOCHEM(SHANGHAI) CO.,lTD